Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$2.6B |
| 2 |
Abbott
ABT
|
+$1.29B |
| 3 |
Home Depot
HD
|
+$1.03B |
| 4 |
Devon Energy
DVN
|
+$888M |
| 5 |
PepsiCo
PEP
|
+$880M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$1.6B |
| 2 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$1.5B |
| 3 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$1.34B |
| 4 |
Texas Instruments
TXN
|
+$1.32B |
| 5 |
Coterra Energy
CTRA
|
+$789M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.11% |
| 2 | Financials | 10.61% |
| 3 | Healthcare | 10.33% |
| 4 | Miscellaneous | 9.93% |
| 5 | Industrials | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1101
Rhythm Pharmaceuticals
RYTM
$6.18B
| $61.4M | 0.01% |
552,738
+26,279
| +5% | +$2.38M |
2017 Q4
34 quarters
|
|
1102
Core Natural Resources Inc
CNR
$4.54B
| $61.3M | 0.01% |
766,054
-8,512
| -1% | -$754K |
2017 Q4
34 quarters
|
|
1103
Maplebear
CART
$11.8B
| $61.1M | 0.01% |
1,290,788
-35,206
| -3% | -$1.47M |
2024 Q2
8 quarters
|
|
1104
Ligand Pharmaceuticals
LGND
$6.18B
| $61.1M | 0.01% |
193,238
+10,351
| +6% | +$2.44M |
2013 Q2
52 quarters
|
|
1105
Boot Barn
BOOT
$3.67B
| $61.1M | 0.01% |
371,752
+4,844
| +1% | +$786K |
2014 Q4
46 quarters
|
|
1106
Kontoor Brands
KTB
$3.7B
| $61M | 0.01% |
732,263
-1,412
| -0.2% | -$103K |
2019 Q2
28 quarters
|
|
1107
Planet Labs
PL
$5.56B
| $61M | 0.01% |
1,841,945
-437,451
| -19% | -$16.2M |
2022 Q1
17 quarters
|
|
1108
SEI Investments
SEIC
$12.6B
| $61M | 0.01% |
695,446
-1,027
| -0.1% | -$89.6K |
2013 Q2
52 quarters
|
|
1109
Acadia Healthcare
ACHC
$2.85B
| $60.9M | 0.01% |
2,062,966
+162,019
| +9% | +$4.16M |
2013 Q2
52 quarters
|
|
1110
Urban Edge Properties
UE
$2.47B
| $60.8M | 0.01% |
2,658,155
+86,768
| +3% | +$1.91M |
2015 Q1
45 quarters
|
|
1111
First Financial Bankshares
FFIN
$4.46B
| $60.8M | 0.01% |
1,757,759
+31,098
| +2% | +$1M |
2013 Q2
52 quarters
|
|
1112
Kymera Therapeutics
KYMR
$9.28B
| $60.7M | 0.01% |
529,729
+34,467
| +7% | +$2.96M |
2020 Q4
22 quarters
|
|
1113
Sprouts Farmers Market
SFM
$6.03B
| $60.6M | 0.01% |
717,067
+3,614
| +0.5% | +$292K |
2013 Q3
51 quarters
|
|
1114
DELISTED
Janus Henderson
JHG
| $60.6M | 0.01% |
1,166,170
-627,213
| -35% | -$32.4M |
2017 Q2
36 quarters
|
|
1115
Oscar Health
OSCR
$10.7B
| $60.5M | 0.01% |
2,119,863
+221,118
| +12% | +$4.76M |
2021 Q2
20 quarters
|
|
1116
Synaptics
SYNA
$4.74B
| $60.4M | 0.01% |
486,385
-37,503
| -7% | -$4.23M |
2013 Q2
52 quarters
|
|
1117
Schwab US Mid-Cap ETF
SCHM
$14.6B
| $60.4M | 0.01% |
1,636,994
+452,264
| +38% | +$15.6M |
2025 Q2
4 quarters
|
|
1118
Gentex
GNTX
$4.41B
| $60.3M | 0.01% |
2,386,873
-51,001
| -2% | -$1.21M |
2013 Q2
52 quarters
|
|
1119
German American Bancorp
GABC
$1.85B
| $60.3M | 0.01% |
1,270,252
+117,557
| +10% | +$5.17M |
2013 Q2
52 quarters
|
|
1120
Covista Inc
CVSA
$4.43B
| $60.2M | 0.01% |
483,276
-16,969
| -3% | -$2.04M |
2013 Q2
52 quarters
|
|
1121
Novartis
NVS
$275B
| $60.2M | 0.01% |
384,386
+38,976
| +11% | +$5.84M |
2019 Q1
29 quarters
|
|
1122
Fulton Financial
FULT
$4.26B
| $60.2M | 0.01% |
2,486,802
+36,526
| +1% | +$801K |
2013 Q2
52 quarters
|
|
1123
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$20.5B
| $59.9M | 0.01% |
1,193,049
+13,158
| +1% | +$661K |
2023 Q3
11 quarters
|
|
1124
Cal-Maine
CALM
$3B
| $59.9M | 0.01% |
743,541
+38,417
| +5% | +$2.97M |
2013 Q2
52 quarters
|
|
1125
Belden
BDC
$4.1B
| $59.9M | 0.01% |
499,429
+3,852
| +0.8% | +$449K |
2013 Q2
52 quarters
|
|
Similar funds
Charles Schwab's Q2 2026 Portfolio in Review
As of Q2 2026, Charles Schwab held 3,591 positions worth $751B, up 15% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Charles Schwab's Q2 2026 filing shows 136 new, 2,145 increased, 1,132 reduced and 153 closed positions. Its largest new stake was Honeywell Aerospace: 2,031,187 shares worth $449M. The largest sale was Qualcomm, an estimated $1.6B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2026 buy was Honeywell Aerospace: 2,031,187 shares worth $449M.
- Charles Schwab added most to Schwab US Large-Cap Growth ETF in Q2 2026, an estimated $2.6B increase.
- Charles Schwab's biggest Q2 2026 reduction was Qualcomm, cutting an estimated $1.6B.
- Charles Schwab fully exited Coterra Energy in Q2 2026, selling an estimated $789M.
- Charles Schwab's ten largest holdings make up 22% of its $751B portfolio in Q2 2026.
- Charles Schwab opened 136 new positions and closed 153 in Q2 2026.
- Charles Schwab's portfolio value rose 15% quarter-over-quarter to $751B.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.